Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease

SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease

US Patent 10500186 · Granted Dec 10, 2019

Estimated economic value: $188,033,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating or reducing the risk of cardiovascular events and related di2024
Methods of treating or reducing the risk of cardiovascular events and related di2024
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2020
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2020
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2020
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2020
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2019
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2019
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2019
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2019
Methods for treating cardiovascular disease using a soluble CTLA4 molecule2010
Methods for treating immune disorders associated with graft transplantation with2009